» Authors » Yuki Shimada

Yuki Shimada

Explore the profile of Yuki Shimada including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 68
Citations 374
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Tsutsumi C, Ohuchida K, Tsutsumi H, Shimada Y, Yamada Y, Son K, et al.
Cancer Lett . 2024 Dec; 611:217412. PMID: 39722406
Therapies targeting HER2 are the standard treatment for HER2-positive gastric cancer (GC). Trastuzumab, a monoclonal antibody against HER2, exerts anti-tumor activity through cell growth regulation and antibody-dependent cellular cytotoxicity (ADCC)....
2.
Zhang J, Mizuuchi Y, Ohuchida K, Hisano K, Shimada Y, Katayama N, et al.
Cancer Sci . 2024 Dec; 116(2):500-512. PMID: 39623744
Patients with colorectal cancer (CRC) following renal transplantation require long-term immunosuppressants to prevent graft rejection. However, the impact of these immunosuppressants on the tumor immune microenvironment and the roles of...
3.
Higuchi A, Yoshimura H, Saito H, Abe T, Murakami M, Zhao T, et al.
Sci Rep . 2024 Nov; 14(1):29022. PMID: 39578656
After the Great East Japan Earthquake, planning appropriate healthcare resource allocation was crucial. However, accurately estimating medical care demand was challenging due to substantial population fluctuations caused by extensive evacuations,...
4.
Kato M, Shiosakai M, Kuwahara K, Iba K, Shimada Y, Saito M, et al.
CNS Drugs . 2024 Oct; 38(12):1003-1016. PMID: 39424742
Background And Objective: Inadequate response to antidepressant monotherapy is common among patients with major depressive disorder (MDD). The efficacy and safety of adjunctive brexpiprazole 2 mg/day has recently been confirmed...
5.
Ezoe A, Shimada Y, Sawada R, Douke A, Shibata T, Kadowaki M, et al.
Mol Inform . 2024 Oct; 43(11):e202400108. PMID: 39404192
Multiherbal medicines are traditionally used as personalized medicines with custom combinations of crude drugs; however, the mechanisms of multiherbal medicines are unclear. In this study, we developed a novel pathway-based...
6.
Zhang B, Ohuchida K, Tsutsumi C, Shimada Y, Mochida Y, Oyama K, et al.
J Exp Clin Cancer Res . 2024 Sep; 43(1):271. PMID: 39343933
Background: Pancreatic ductal adenocarcinoma tumors exhibit resistance to chemotherapy, targeted therapies, and even immunotherapy. Dendritic cells use glucose to support their effector functions and play a key role in anti-tumor...
7.
Shimizu M, Beck G, Murayama S, Hoshi T, Sumikura H, Higashida K, et al.
Front Immunol . 2024 Sep; 15:1426236. PMID: 39267735
Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) has highly heterogeneous clinical presentations, in which encephalitis is an important phenotype. Moreover, MOGAD has been reported to exhibit diverse imaging findings. However, there...
8.
Luo H, Ikenaga N, Nakata K, Higashijima N, Zhong P, Kubo A, et al.
J Exp Clin Cancer Res . 2024 Sep; 43(1):258. PMID: 39261943
Background: Tumor-associated neutrophils (TANs) constitute an abundant component among tumor-infiltrating immune cells and have recently emerged as a critical player in pancreatic ductal adenocarcinoma (PDAC) progression. This study aimed to...
9.
Sumikura H, Ito M, Sato T, Hatayama N, Fujioka T, Nagashima N, et al.
Intern Med . 2024 Apr; 63(23):3237-3241. PMID: 38569911
A 44-year-old woman with a subacute onset of an altered mental status, urinary retention, and fluctuating blood pressure was initially diagnosed with anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis, meeting the criteria of...
10.
Shimada Y, Todo K, Doijiri R, Yamazaki H, Sonoda K, Koge J, et al.
Stroke . 2024 Mar; 55(4):946-953. PMID: 38436115
Background: Covert atrial fibrillation (AF) is a major cause of cryptogenic stroke. This study investigated whether a dose-dependent relationship exists between the frequency of premature atrial contractions (PACs) and AF...